Trial Search Results

The Dynamics of Human Atrial Fibrillation

The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

University of California, San Diego

Collaborator: National Heart, Lung, and Blood Institute (NHLBI)

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   - Subjects will be patients undergoing electrophysiology study and ablation for
   paroxysmal or persistent atrial fibrillation (AF) after having failed >or= 1
   anti-arrhythmic drug.

Ages Eligible for Study

21 Years - 80 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Kathleen Mills
(858) 449-3252
Not Recruiting